- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles
- Arizona behavioral health center adds 10 adolescent beds
- The explosion of the Medicare Advantage special needs plan
- The explosion of the Medicare Advantage special needs plan
- We’re Great Thinkers…But Not Rethinkers
- North Star to cut additional jobs
- North Star to cut additional jobs
- Oregon Governor asks PeaceHealth to delay contract switch: 11 things to know
- 6 Optum updates to know from Q1
- Viewpoint: US nursing workforce faces several risks
- The shifting dental hygiene landscape
- 12 dental insurance updates in 30 days
- ‘The 1980s called’: CMS to phase out fax, mail
- ‘The 1980s called’: CMS to phase out fax, mail
- Aligning IT & clinical teams: How to reduce friction and improve communication
- AI tool targets billing gaps at Kentucky system
- AI in pharmacy: Why pilots stall at hospitals
- 37 recent hospital, health system executive moves
- This ASC startup is wiring AI into the fabric of outpatient surgery
- Springer Nature retracts 38 papers over autism dataset
- Intermountain plans new outpatient clinic
- Legacy Health, Regence BCBS face looming contract expiration
- Meet the COOs of the largest DSOs
- Michigan bills target outpatient fees, CON requirements
- Anesthesia group, lawmakers oppose Medicare cuts to non-opioid pain treatment
- Iowa lifts emergency suspension of transplant surgeon’s license
- Vascular center, physician CEO to pay $4M to settle fraud allegations
- In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut
- 5 cardiologists stepping into leadership roles
- New York organizations partner on intellectual, developmental disabilities campus
- Cincinnati hospital acquires outpatient center for $6M
- CMS final rule aims to ax the fax machine, phase out paper mailing
- 24 profitable health systems in 2025
- How 2 CFOs plan for uncertainty
- Heartland Dental expands with Texas affiliation
- MD Anderson opens colorectal cancer center
- SALT Dental Partners adds Washington practice
- 11 dental school updates to know
- 6 health systems seeking revenue cycle executive directors
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Integrated care model drives 76% depression improvement in 44 days: Study
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Idaho bill proposes consolidating dental regulatory oversight
- Washington hospital charts path to preserve primary care
- 4 DSOs making headlines
- 6 state behavioral health policy updates
- 80% of returning ACA enrollees report higher healthcare costs in 2026
- Fitch downgrades HonorHealth’s credit rating
- NYC Health + Hospitals names dentistry, oral surgery leaders
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics
- Sanofi backs 2 more documentary films about rare blood disorders
- ACIP member's miscommunication on vaccine panel's future adds to confusion after court ruling
- Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity
- Some Patients With ADHD and Addiction History Missing Out
- Social Media Poses Risks to Children's Mental Health, Review Concludes
- Does Closing Your Eyes Help You Hear Better?
- 'Early Bird' Exercisers Get The Most Health Benefits, Study Finds
- High Blood Pressure Deaths Quadruple Among Young Women, Study Finds
- Meningitis Vaccine Doesn't Protect Gay, Bisexual Men From Gonorrhea, Clinical Trial Concludes
- ‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
- Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
- Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota
- Mississippi to fund clinical trials for psychedelic drug
- Lawmakers push bill to boost mental health workforce, diversity
- Florida State partners with behavioral health provider on research
- Utah governor signs hygienist autonomy bill
- UHS CEO: Talkspace deal builds 1st national ‘end-to-end’ behavioral model
- Psychedelic therapy shows no benefit over antidepressants: Study
- What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now
- Verily banks $300M to accelerate AI road map, transitions to independent company
- KFF: ACA plan enrollees report rising costs for 2026 coverage
- Industry Voices—Stop buying AI tools, start designing AI architecture
- CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix
- 10K Corewell Health nurses vote to authorize labor strike
- Providence mulling sale of its health plan amid financial pressures
- Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup
- Gut Microbiome May Take Years to Recover From Antibiotic Use
- Prepared Remarks Before SEC Speaks
- The Art and Science of Materiality
- Capital, Choice, and the Pursuit of Happiness: Remarks at The SEC Speaks in 2026
- Novo's Wegovy HD passes muster under FDA national priority voucher program
- Hospital operations begin 2026 with depressed margins amid low volumes, high labor spend
- The Math Behind Eczema Flare-Ups May Finally Add Up
- Male preconception startup Upstream announces donor-matching platform
- Women's health sector could grow to $600B industry by 2030: PwC report
- Democratic senators detail plans to take on 'Big Insurance'
- Both Types Of Diabetes Increase Dementia Risk
- Aldi Recalls Spinach Bites Over Possible Contamination
- Collegium ponies up $650M to gain ADHD drug Azstarys from Corium
- Maryland bill calls for more transparency in pharma's disease awareness campaigns
- After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease
- What To Know About Fatty Liver Disease and Why It’s So Common
- Drug Smoking Linked To Surge In Severe Burn Cases
- Thymus Gland Health May Be Key to Long Life and Fighting Cancer
- Premature Menopause Increases Heart Disease Risk
- U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Pesticide Exposure Before Pregnancy Might Risk Newborn Health
- UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
- Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds.
- Lawmakers Seek To Protect Crisis Pregnancy Centers as Abortion Clinic Numbers Shrink
- Oz Says California’s Not Fighting Health Care Fraud, but Data Shows It’s Part of a Larger Battle
- Watch: Affordability Plagues Health Care in Its Shift From Nonprofit to Profit Machine
- CDMO Axplora to pump $60M into Italian complex API plant
- Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- Turquoise Health raises $40M to power healthcare contracts, payments
- To tackle healthcare costs, representatives weigh curbs on provider consolidation
- A look at Highmark's specialty pharmacy partnership with Free Market Health
- AD/PD 2026: New data highlight potential cost-effectiveness of confirmatory AD blood testing in U.S. diagnostic pathways
- With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
- TrumpRx's 'world's lowest' drug price claims fall short in global comparison: NYT
- Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
- J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval
- Belly Fat Linked To Heart Failure Risk
- Women More Likely To Survive Cancer Than Men — At A Cost
- BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists
- Sandoz expands biosim collab with Samsung Bioepis, sets sights on Takeda's Entyvio
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
- E. Coli Outbreak Tied To Raw Cheddar Cheese Sickens 7 People
- The Sunshine Vitamin and COVID: New Study Finds Mixed Results for Recovery
- Too Much Smartphone Use Linked to Disordered Eating in Teens
- Shingles Vaccine Protects Heart Failure Patients From Heart Attack, Stroke
- White House Chief of Staff Susie Wiles Diagnosed With Early Breast Cancer
- Gates-backed TerraPower Isotopes blueprints $450M plant to supply next wave of radiopharmaceuticals
- Regulation Crypto Assets: A Token Safe Harbor
- The Last Chapter in the Book of Howey
- Payers, hospitals pan CMS' plan to bring non-network plans to ACA exchanges
- Optum Real and Suki build out collaboration to tackle payment challenges as R1 teams with AI scribe Heidi
- Indiana homes in on life sciences with $1B growth strategy, plan to create 100K jobs
- Moody's: Insurers' 2026 outlook is negative as cost pressures continue to batter industry
- GSK's management of Flovent allowed it to 'game the system': Hassan
- Allina Health to join Sutter Health in $26B proposed transaction
- Norovirus Sickens Close to 200 People on Caribbean Cruise
Corewell Health must have received the same DoJ subpoena that Michigan Medicine did. Corewell just announced that they will no longer provide "gender-affirming care" for minors. Attorney General Nessel has not yet threatened Corewell for stopping transgender treatments, but she should weigh in later today:
Corewell is latest state health system to halt gender-affirming care for trans minors
By Georgea Kovanis - September 10, 2025Key Points
* Corewell Health is latest Michigan hospital to halt gender-affirming care for minors.
* Michigan Medicine, the University of Michigan health care system, cited pressure from the Trump administration when it halted gender-affirming care for patients under 19 years of age last month.
* Equality Michigan, a LGBTQ+ advocacy organization, decried Corewell's decision.Citing the "serious risk of legal action," Corewell Health on Sept. 10 became the latest Michigan health care system to discontinue gender-affirming care for minors.
A statement provided to the Free Press by Corewell said: "Given the serious risk of legal and regulatory action, Corewell Health will no longer prescribe puberty blockers or hormone therapy to minors for gender affirmation. Like many health care systems across the country, we made this decision to protect both our health care providers and our patients. We will continue to compassionately address the health needs of our patients who are in transition or wish to transition, including providing mental health support."
Last month, under pressure from the Trump administration, Michigan Medicine, the University of Michigan's health system, halted gender-affirming care for patients under the age of 19, which is the age President Donald Trump specified in his executive order threatening to strip federal funding from hospitals and providers offering offer gender-affirming care to young people. Corewell said it would no longer provide care to minors. Generally, minors are considered under 18 years of age, not under 19. When asked for clarification on the matter, Corewell spokesman Mark Geary referred the Free Press to the prepared statement the hospital issued.
Hospital systems and doctors who provide gender-affirming care to minors have been under increasing pressure to stop the practice since Trump's executive order earlier this year.
In July, the U.S. Department of Justice said it sent more than 20 subpoenas to hospitals and doctors that provide gender-affirming care to minors.
"The University of Michigan, including Michigan Medicine, is one of multiple institutions across the country that has received a federal subpoena as part of a criminal and civil investigation into gender-affirming care for minors," according to a statement released by Michigan Medicine at the time of its decision to halt treatments for young people.
The exact content of the Michigan Medicine subpoenas is unclear, though a person familiar with the situation who spoke on the condition of anonymity said the subpoenas asked for patient information and medical records. Documents filed in association with a lawsuit against the Trump administration show that a subpoena for the Children's Hospital of Philadelphia also requested patient medical records.
Geary didn't respond when asked if Corewell was subpoenaed by the Justice Department.
That health system's decision came one day after a federal judge in Massachusetts quashed a Justice Department subpoena served on Boston Children's Hospital. In his decision, U.S. District Judge Myong Joun wrote that the Justice Department subpoena's requests for documents were "overbroad." He also wrote: "The Administration has been explicit about its disapproval of the transgender community and its aim to end (gender-affirming care)" and that the "subpoena reflects those goals."
Equality Michigan, a LGBTQ+ advocacy organization expressed disappointment over Corewell's decision. “It is devastating to see yet another healthcare giant turn its back on transgender youth and their families," said Erin Knott, Equality Michigan's executive director. "Corewell’s decision underscores a disturbing pattern. Institutions that should be at the forefront of providing compassionate, evidence-based care are instead retreating under political pressure, leaving vulnerable young people to shoulder the harm."This is not just a matter of policy, it’s a matter of lives. Families who once relied on Corewell now face having their care taken away, and trans youth are left with the message that their health and well-being are expendable."
Gender-affirming care for young people is legal in Michigan.
When Michigan Medicine stopped gender-affirming care for minors, Michigan Attorney General called the health system "cowardly" and "shameful" for yielding to Trump's pressure.
In an open letter to patients and providers, Nessel said: "Refusing healthcare services to a class of individuals based on their protected status, such as withholding the availability of services from transgender individuals based on their gender identity or their diagnosis of gender dysphoria, while offering such services to cisgender individuals, may constitute discrimination under Michigan law.”
In February, Corewell discontinued gender-affirming treatment for new minor patients but reversed its decision days later.
Corewell Health owns hospitals throughout Michigan, historically its Corewell East hospitals, those in metro Detroit, have not provided gender-affirming care to minors. That treatment has been handled by Corewell West in west Michigan.
Attorney General Nessel's reply. In light of the Charlie Kirk assassination (OwO) and the Annunciation Church shootings, she is being more circumspect in her legal threats encouraging transgender empowerment:
Attorney General Nessel Statement on Corewell Health’s Recent Announcement Regarding Transgender Healthcare
By Danny Wimmer - September 12, 2025LANSING – Michigan Attorney General Dana Nessel released the following statement in response to Corewell Health’s recent announcement to end certain care to minors for gender affirmation:
“The decision by Corewell Health to end certain forms of essential healthcare for minors is deeply disappointing. They have chosen to capitulate to the federal administration’s discriminatory campaign against the trans community, despite Corewell not being a target of any federal action in this realm. Corewell’s shortsighted approach to conform their treatment options and “obey in advance” fails to adequately consider the long-term consequences to the health, safety and well-being of their patients. Michigan law has not changed; gender affirming care remains legal and is approved healthcare by leading healthcare associations.
“The hospitals that choose to disregard science, best practices, and the recommendations of every major medical society in America create a dangerous precedent that could have long-lasting implications on all patients. We have seen virtue signaling from the federal administration that they intend to detrimentally attack many other areas of public health and medical treatment. We must ask ourselves: what other medical practices or care will this Administration target next – reproductive care, vaccines, scientific studies - and will our healthcare institutions quickly succumb to such pressure each and every time?
“The Department of Attorney General has already filed suit to challenge (PDF) the Trump Administration's unlawful actions targeting providers of gender affirming care for youth. And at least one court has found the Trump administration’s malicious investigation efforts against a medical provider to be unlawful (PDF). We urge healthcare institutions in Michigan to join our office and other institutions in fighting back against the federal government’s incursion into personal and sensitive healthcare decisions. These sensitive healthcare matters should not be determined by the government, but by parents in concert with their children and their family’s medical providers.
“The Department of Attorney General stands with all of Michigan’s patients and the many medical institutions that continue to respect the law, eschew the discriminatory actions preferred by the federal administration, adhere to science as practiced and prescribed by expert physicians, and choose to take on the fight against those targeting their patients for political purposes.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















